Tempus is a technology company that is building the world’s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. Tempus provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Tempus is working with leading academic medical centers, NCI designated cancer centers, hospital networks and community oncologists across the United States. The Tempus platform touches nearly 1 in 4 cancer patients in the United States.